Initiation of anaemia management in patients with chronic kidney disease not on dialysis in the Veterans Health Administration
Author(s) -
Elizabeth Lawler,
David R. Gag,
Jeffrey C. Fink,
Stephen L. Seliger,
Jennifer R. Fonda,
Adrian P. Trifa,
J. Michael Gaziano,
Brian D. Bradbury
Publication year - 2010
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfp758
Subject(s) - medicine , kidney disease , dialysis , nephrology , renal replacement therapy , odds ratio , retrospective cohort study , anemia , logistic regression , cohort , renal function , intensive care medicine
Erythropoiesis-stimulating agents (ESAs) are frequently used to treat anaemia of chronic kidney disease (CKD) in the dialysis setting; however, few data are available regarding factors influencing initiation of ESAs and other therapies in non-dialysis patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom